A defendant shall be punished by imprisonment for six months and by a fine of two thousand won.

When the defendant does not pay the above fine.

Punishment of the crime

1. At around 18:30 on May 30, 2013, the Defendant, at a pharmacy operated by the Defendant in Scheon-si B, had D, the husband of the Defendant, not the pharmacy owner, sell 50mmpium 50mp. D, D, the Defendant, the husband of the Defendant, selling d, not D, D, D, the Defendant’s her husband of the Defendant, 10mpinium 50mp. D, P, P, C, the 100mp. g, D, D, D, C, the 25mmp. g, C, the 4mg of C, the C, the C, and D, the pharmacy.

As a result, the Defendant, as an employee, had the above-mentioned sales of drugs.

2. Where a pharmacy founder sells prescription drugs without prescriptions given by a doctor or a dentist, other than an area in which the pharmaceutical business is run, he/she shall sell prescription drugs within the limit of five days based on the matters approved or reported for marketing;

Nevertheless, the Defendant, in collusion with the above D, sold 30-day prescription drugs, such as DNA chlofinium 50mg, Pakistan, 100mg, DNA 25mg, DNA 4mg, mertidine 200mg, mertidine 200mg, and celg selg 30-day prescription drugs, which were prepared by the above A.

3. Every pharmacist shall, if he/she prepares medicines at his/her pharmacy, keep the name of a patient, the date of preparation of medicines, the names of the medicines and the number of days of prescription, the details of preparation of medicines and the details of guidance on taking medicines for five years after entering them in

Nevertheless, from June 1, 2013 to June 28, 2013, the Defendant did not prepare a preparation record while selling medicines to many unspecified patients at the same place.

Summary of Evidence

1. Defendant's legal statement;

1. Examination protocol of police suspect regarding D;

1. Each E statement;

1. Requests for each accusation, investigation, and disposition;

1. A copy of a preparation book;

1. Each photograph;

1. Application of the Acts and subordinate statutes for investigation reporting;

1. Relevant Article 97, Article 93 (1) 7, and Article 44 (1) of the Pharmaceutical Affairs Act concerning facts constituting an offense (the first point on the market), the Pharmaceutical Affairs Act;